Panel recommends regular market approval for Covishield and Covaxin
The Hindu
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting regular market approval to COVID-19 vaccines, Covishield and Covaxin, in the adul
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting regular market approval to COVID-19 vaccines, Covishield and Covaxin, in the adult population, subject to certain conditions, confirmed an official on Wednesday.
Both the vaccines are currently only authorised for emergency use in India and their application was reviewed for the second time on Wednesday before the recommendations were made, he said.
More Related News













